Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Trust iShares Russell 2000 BuyWrite ETF (NY:IWMW)

41.52 +0.45 (+1.10%)
Official Closing Price Updated: 8:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,772
Open 41.56
Bid (Size) 39.75 (1)
Ask (Size) 63.00 (1)
Prev. Close 41.07
Today's Range 41.52 - 41.64
52wk Range 34.29 - 49.18
Shares Outstanding N/A
Dividend Yield 15.64%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Teladoc Stock Shot Up 8% Today: BofA Views It As Differentiated Asset But Remains Cautious On Near-Term Outlook
BofA’s new price target represents a potential upside of about 5% from the stock’s closing price on Thursday. 
Via Stocktwits
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy
CEO Barbara Weber said that across the 16 cancer types enrolled in the trial, the objective response rate (ORR) was 27% in patients with a median follow-up of 9.4 months. 
Via Stocktwits

Performance

YTD
-5.8%
-5.8%
1 Month
+2.8%
+2.8%
3 Month
+4.9%
+4.9%
6 Month
+7.6%
+7.6%
1 Year
-8.4%
-8.4%

More News

Read More
DNUT Stock Trades Above 200-DMA For The First Time Since November 2024
Via Stocktwits
Topics ETFs
Beyond Meat Stock Skyrockets 60% Today: Meme Stock Frenzy Intensifies After ETF Inclusion Amid Surging Retail Buzz
Via Stocktwits
Topics Artificial Intelligence ETFs
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors?
Via Stocktwits
Hillenbrand To Go Private In Nearly $4B Deal With Affiliate Of Lone Star Funds
Via Stocktwits
Planet Labs To Provide Images Within An Hour Using New Earth Observation Satellites: Report
Via Stocktwits
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process
Via Stocktwits
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off?
Via Stocktwits
Applied Digital Stock Soars 7% Pre-Market On $5B AI Factory Lease With US Hyperscaler
Via Stocktwits
Topics Artificial Intelligence
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm
Via Stocktwits
Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity
Via Stocktwits
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment
Via Stocktwits
Plug Power Names Insider Jose Luis Crespo As New CEO
Via Stocktwits
White House Reportedly Denies Plans To Acquire Stake In Critical Metals
Via Stocktwits
Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugs
Via Stocktwits
Topics Intellectual Property
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy
Via Stocktwits
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy
Via Stocktwits
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study
Via Stocktwits
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
Via Stocktwits
AMC Entertainment Stock Is Rising Today And There’s A Taylor Swift Angle – Find Out More
Via Stocktwits
Oklo Stock Continues To Be The Talk Of The Town After Gaining 87% In A Month – Here’s How Retail Investors Responded
Via Stocktwits
This Stock Nearly Doubled In A Month, And It Just Received A Fresh Price Target Hike By Roth Capital – Find Out More
Via Stocktwits
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’
Via Stocktwits
Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details
Via Stocktwits

Frequently Asked Questions

Is iShares Trust iShares Russell 2000 BuyWrite ETF publicly traded?
Yes, iShares Trust iShares Russell 2000 BuyWrite ETF is publicly traded.
What exchange does iShares Trust iShares Russell 2000 BuyWrite ETF trade on?
iShares Trust iShares Russell 2000 BuyWrite ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares Trust iShares Russell 2000 BuyWrite ETF?
The ticker symbol for iShares Trust iShares Russell 2000 BuyWrite ETF is IWMW on the New York Stock Exchange
What is the current price of iShares Trust iShares Russell 2000 BuyWrite ETF?
The current price of iShares Trust iShares Russell 2000 BuyWrite ETF is 41.52
When was iShares Trust iShares Russell 2000 BuyWrite ETF last traded?
The last trade of iShares Trust iShares Russell 2000 BuyWrite ETF was at 10/24/25 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.